We are live on ! Find out more
AI

Alphabet Inc Portfolio holdings

AUM $4.02B
1-Year Est. Return 215.74%
This Fund
S&P 500
This Quarter Est. Return
-6.67%
1 Year Est. Return
+215.74%
3 Year Est. Return
+350.01%
5 Year Est. Return
+242.03%
10 Year Est. Return
+998.87%
AUM
$1.97B
AUM Growth
-$540M
Cap. Flow
-$210M
Cap. Flow %
-10.65%
Top 10 Hldgs %
88.61%
Holding
44
New
1
Increased
1
Reduced
4
Closed
2

Top Buys

Rank Stock Value
1
TEM
Tempus AI
TEM
+$47.6M
2
RVMD icon
Revolution Medicines
RVMD
+$208K

Top Sells

Rank Stock Value
1
CRWD icon
CrowdStrike
CRWD
+$142M
2
DXCM icon
DexCom
DXCM
+$95.3M
3
IVVD icon
Invivyd
IVVD
+$20.1M
4
ILMN icon
Illumina
ILMN
+$168K
5
MOND
Mondee Holdings, Inc. Class A Common Stock
MOND
+$42.5K

Sector Composition

Rank Sector Weight
1 Technology 65.24%
2 Healthcare 31.4%
3 Industrials 3.24%
4 Consumer Staples 0.12%
5 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GTLB icon
1
GitLab
GTLB
$5.28B
$485M 24.58%
9,758,333
– –
ARM icon
2
Arm
ARM
$278B
$321M 16.25%
1,960,784
– –
RVMD icon
3
Revolution Medicines
RVMD
$40.2B
$206M 10.43%
5,307,075
+5,563
+0.1% +$208K
CRWD icon
4
CrowdStrike
CRWD
$187B
$164M 8.31%
1,711,580
-1,711,576
-50% -$142M
FRSH icon
5
Freshworks
FRSH
$2.84B
$157M 7.93%
12,336,643
– –
DXCM icon
6
DexCom
DXCM
$27.6B
$118M 5.96%
1,036,937
-753,836
-42% -$95.3M
PATH icon
7
UiPath
PATH
$5.62B
$89.2M 4.52%
7,034,337
– –
PRME icon
8
Prime Medicine
PRME
$533M
$77.4M 3.92%
15,062,498
– –
SNOW icon
9
Snowflake
SNOW
$92.9B
$72.4M 3.66%
535,604
– –
VERV
10
DELISTED
Verve Therapeutics
VERV
$60.3M 3.05%
12,349,086
– –
PL icon
11
Planet Labs
PL
$7.3B
$59.4M 3.01%
31,942,641
– –
TEM
12
Tempus AI
TEM
$7.69B
$54.3M 2.75%
+1,551,102
New +$47.6M
SANA icon
13
Sana Biotechnology
SANA
$885M
$15.4M 0.78%
2,812,500
– –
RLAY icon
14
Relay Therapeutics
RLAY
$4.02B
$10.2M 0.52%
1,568,753
– –
VERA icon
15
Vera Therapeutics
VERA
$2.54B
$8.73M 0.44%
241,264
– –
LYEL icon
16
Lyell Immunopharma
LYEL
$309M
$8.5M 0.43%
293,256
– –
OSCR icon
17
Oscar Health
OSCR
$8.5B
$7.63M 0.39%
481,988
– –
BEAM icon
18
Beam Therapeutics
BEAM
$2.58B
$7.54M 0.38%
321,604
– –
TCRX icon
19
TScan Therapeutics
TCRX
$51.9M
$6.3M 0.32%
1,077,080
– –
ILMN icon
20
Illumina
ILMN
$29.4B
$5.58M 0.28%
53,470
-1,497
-3% -$168K
GLUE icon
21
Monte Rosa Therapeutics
GLUE
$1.92B
$5.48M 0.28%
1,464,015
– –
DNTH icon
22
Dianthus Therapeutics
DNTH
$5.68B
$5.4M 0.27%
208,697
– –
DM
23
DELISTED
Desktop Metal, Inc.
DM
$4.56M 0.23%
1,104,871
-2
-0% -$14
FHTX icon
24
Foghorn Therapeutics
FHTX
$285M
$2.88M 0.15%
500,901
– –
TNYA icon
25
Tenaya Therapeutics
TNYA
$168M
$2.84M 0.14%
915,705
– –
1
2

Similar funds

JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
MGP
Metis Global Partners San Diego, California $4.07B AUM 30.82% 1-Year Est. Return

Alphabet Inc's Q2 2024 Portfolio in Review

As of Q2 2024, Alphabet Inc held 44 positions worth $1.97B, down 21% from $2.51B the previous quarter. Its ten largest holdings account for 89% of the portfolio.

Alphabet Inc withdrew a net $210M in Q2 2024, closing 2 positions and reducing 4 holdings. Its most notable exit was Invivyd, an estimated $20.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 65% of assets, up from 62% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Alphabet Inc opened a new position in Tempus AI worth $54.3M.

  • Alphabet Inc's largest Q2 2024 buy was Tempus AI: 1,551,102 shares worth $54.3M.
  • Alphabet Inc added most to Revolution Medicines in Q2 2024, an estimated $208K increase.
  • Alphabet Inc's biggest Q2 2024 reduction was CrowdStrike, cutting an estimated $142M.
  • Alphabet Inc fully exited Invivyd in Q2 2024, selling an estimated $20.1M.
  • Alphabet Inc's ten largest holdings make up 89% of its $1.97B portfolio in Q2 2024.
  • Alphabet Inc opened 1 new position and closed 2 in Q2 2024.
  • Alphabet Inc's portfolio value fell 21% quarter-over-quarter to $1.97B.

Based on Alphabet Inc's 13F filing for Q2 2024, filed 2 Aug 2024.